SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation that cannabis rescheduling may be imminent, with some anticipating a resulting sector-wide surge. The community is actively discussing the potential impact of a presidential executive order on tax relief and banking access. Some investors are optimistic about a short squeeze, while others remain cautious due to the company's history.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to the upcoming launch of BlueBird 6, marking a significant step towards a launch cadence of approximately every 45 days in 2026; this represents a shift from concept to operational deployment. The community is buzzing about the potential for a Starlink competitor and the company's long-term prospects, with some highlighting the high short interest and potential for a squeeze.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending due to its active community and ongoing initiatives, particularly the upcoming availability of Kendu Spice on Amazon. The community is actively discussing the project's strong IRL presence and the numerous businesses being built around the KENDU brand. Many see it as a long-term play with a dedicated and growing community.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis is trending amidst reports that Trump may consider rescheduling marijuana, potentially affecting taxation and medical access. The community is discussing the potential impact of this policy change and whether it will be a "sell the news" event. Scanners continue to light up as cannabis tickers show increased interest in response to the news.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to speculation of a potential short squeeze, driven by its low float and recent AI deal. Community members are actively discussing key breakout levels and anticipating a significant price surge. The stock is drawing comparisons to other low-float runners, fueling excitement around potential for substantial gains.

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

BBIO is trending due to analyst upgrades and positive sentiment around the launch of Attruby, with the community actively discussing its potential to outperform competitors and the impact of upcoming Phase 3 readouts. Community members are weighing its growth potential in the context of a potentially undervalued biotech, while also considering the potential for acquisition by a major pharmaceutical company. Actionable trade alerts highlight possible entry and exit points based on technical analysis.

Gunz

Gunz ($GUN) is trending amid community excitement about potential breakouts and large whale buys, with some eyeing a return to all-time highs. The token is also getting attention due to its association with the Off The Grid (OTG) web3 game on the Avalanche network ($AVAX), leading to discussions about its tokenomics and potential for quick gains.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power ($SMR) is trending due to discussions around its potential role in powering AI data centers and a recent agreement with the Tennessee Valley Authority, though concerns persist around its financial performance and Fluor's stake monetization. The community is weighing the company's regulatory advantages and the increasing need for SMR technology against factors like potential share dilution and competition in the sector. Recent analyst target price reductions and overall nuclear sector bearishness may also be contributing to the conversation.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to positive reactions to its AI and autonomy day, with discussions focusing on the potential of its new in-house AI chip and self-driving capabilities. The community is weighing the company's advancements against competitors like Tesla and speculating on a possible short squeeze. Some investors are concerned about cash burn and the timeline for seeing returns on these new technologies.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as speculation mounts around potential federal cannabis policy changes, specifically regarding rescheduling. Community chatter revolves around whether an executive order will materialize, with some anticipating a significant sector-wide surge while others remain cautiously optimistic due to past disappointments. The ETF's exposure to US cannabis companies positions it to potentially benefit from any regulatory easing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Norges Bank Makes New $2.16 Million Investment in AbCellera Biologics Inc. $ABCL

Norges Bank bought a new stake in AbCellera Biologics Inc. (NASDAQ:ABCL - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission...

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. A live audio webcast of the presentation may be...

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

AbCellera (Nasdaq: ABCL) today announced the appointment of Stephen Quake, D.Phil., to its Board of Directors as an independent director. Dr. Quake is a distinguished scientist, inventor, and...

AbCellera Biologics (NASDAQ:ABCL) Posts Quarterly Earnings Results

AbCellera Biologics (NASDAQ:ABCL - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus...

AbCellera Biologics (NASDAQ:ABCL) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded shares of AbCellera Biologics from a "hold" rating to a "sell" rating in a research report on Saturday...

AbCellera Biologics (NASDAQ:ABCL) Shares Gap Down - What's Next?

AbCellera Biologics (NASDAQ:ABCL) Shares Gap Down - What's Next...

AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates

ABCELLERA BIOLG (ABCL) delivered earnings and revenue surprises of -11.76% and +35.31%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

AbCellera Reports Q3 2025 Business Results

AbCellera (Nasdaq: ABCL) today announced financial results for the third quarter of 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated...

Is ABCELLERA BIOLG (ABCL) Stock Outpacing Its Medical Peers This Year?

Here is how AbCellera Biologics Inc. (ABCL) and Astrazeneca (AZN) have performed compared to their sector so far this year.

AbCellera Biologics Inc. (ABCL) is a Great Momentum Stock: Should You Buy?

Does AbCellera Biologics Inc. (ABCL) have what it takes to be a top stock pick for momentum investors? Let's find out.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

ABCL
AbCellera Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABCL News

ABCLAbCellera Biologics Inc